[Federal Register Volume 79, Number 7 (Friday, January 10, 2014)]
[Notices]
[Pages 1889-1890]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-00200]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
Cayman Chemical Company
Pursuant to 21 CFR 1301.33(a), this is notice that on June 27,
2013, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor,
Michigan 48108, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
4-Methyl-N-methylcathinone (1248).......... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Aminorex (1585)............................ I
4-Methylaminorex (cis isomer) (1590)....... I
Gamma Hydroxybutyric Acid (2010)........... I
JWH-250 (6250)............................. I
SR-18 also known as RCS-8 (7008)........... I
XLR11 (7011)............................... I
JWH-019 (7019)............................. I
AKB48 (7048)............................... I
JWH-081 (7081)............................. I
SR-19 also known as RCS-4 (7104)........... I
1-Pentyl-3-(1-naphthoyl)indole (7118)...... I
JWH-122 (7122)............................. I
UR-144 (7144).............................. I
1-Butyl-3-(1-naphthoyl)indole (7173)....... I
1-[2-(4-Morpholinyl)ethyl]-3-.............. I
(1-naphthoyl) indole (7200)................
AM-2201 (7201)............................. I
JWH-203 (7203)............................. I
Alpha-ethyltryptamine (7249)............... I
5-(1,1-Dimethylheptyl)-2-[(1R,3S)- 3- I
hydroxycyclohexyl]-phenol (7297).
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3- I
hydroxycyclohexyl]-phenol (7298).
Lysergic acid diethylamide (7315).......... I
2,5-Dimethoxy-4-(n)- I
propylthiophenethylamine (7348).
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
2C-T-2 (7385).............................. I
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
[[Page 1890]]
2,5-Dimethoxyamphetamine (7396)............ I
JWH-398 (7398)............................. I
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
4-Methoxyamphetamine (7411)................ I
5-Methoxy-N-N-dimethyltryptamine (7431).... I
Alpha-methyltryptamine (7432).............. I
Bufotenine (7433).......................... I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
5-Methoxy-N,N-diisopropyltryptamine (7439). I
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
N-Benzylpiperazine (7493).................. I
2C-D (7508)................................ I
2C-E (7509)................................ I
2C-H (7517)................................ I
2C-I (7518)................................ I
2C-C (7519)................................ I
2C-N (7521)................................ I
2C-P (7524)................................ I
2C-T-4 (7532).............................. I
MDPV (7535)................................ I
Methylone (7540)........................... I
AM-694 (7694).............................. I
Desmorphine (9055)......................... I
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Morphine-N-oxide (9307).................... I
Normorphine (9313)......................... I
Tilidine (9750)............................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Lisdexamfetamine (1205).................... II
Pentobarbital (2270)....................... II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Levomethorphan (9210)...................... II
Meperidine (9230).......................... II
Meperidine intermediate-B (9233)........... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture reference standards for
distribution to their research and forensics customers.
In reference to drug code 7360 (Marihuana), the company plans to
bulk manufacture cannabidiol as a synthetic intermediate. This
controlled substance will be further synthesized to bulk manufacture a
synthetic tetrahydrocannabinol (7370). No other activity for this drug
code is authorized for this registration.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODW), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than March 11, 2014.
Dated: December 31, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2014-00200 Filed 1-9-14; 8:45 am]
BILLING CODE 4410-09-P